miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.

Activating K-Ras mutations occurs frequently in pancreatic cancers and is implicated in their development. Cancer-initiating events, such as oncogenic Ras activation, lead to the induction of cellular senescence, a tumor suppressor response. During senescence, the decreased levels of KDM4A lysine demethylase contribute to p53 activation, however, the mechanism by which KDM4A is downregulated is unknown. We show that miR-137 targets KDM4A mRNA during Ras-induced senescence and activates both p53 and retinoblastoma (pRb) tumor suppressor pathways. Restoring the KDM4A expression contributed to bypass of miR-137-induced senescence and inhibition of endogenous miR-137 with an miRNA sponge-compromised Ras-induced senescence. miR-137 levels are significantly reduced in human pancreatic tumors, consistent with previous studies revealing a defective senescence response in this cancer type. Restoration of miR-137 expression inhibited proliferation and promoted senescence of pancreatic cancer cells. These results suggest that modulating levels of miR-137 may be important for triggering tumor suppressor networks in pancreatic cancer.

[1]  D Saur,et al.  Oncogenic KRAS signalling in pancreatic cancer , 2014, British Journal of Cancer.

[2]  Bicheng Zhang,et al.  microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. , 2015, International journal of biological macromolecules.

[3]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[4]  A. Dejean,et al.  Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells , 2012, Nature Cell Biology.

[5]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[6]  Channing J Der,et al.  KRAS: feeding pancreatic cancer proliferation. , 2014, Trends in biochemical sciences.

[7]  H. Hermeking The miR-34 family in cancer and apoptosis , 2010, Cell Death and Differentiation.

[8]  G. Lou,et al.  miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. , 2013, Biochemical and biophysical research communications.

[9]  W. Filipowicz,et al.  Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. , 2004, RNA.

[10]  J. Nevins,et al.  E2F transcription factor is a target for the RB protein and the cyclin A protein. , 1991, Cold Spring Harbor symposia on quantitative biology.

[11]  Jason A. Koutcher,et al.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis , 2005, Nature.

[12]  H. Vogel,et al.  CHD5 Is a Tumor Suppressor at Human 1p36 , 2007, Cell.

[13]  S. Lowe,et al.  Probing tumor phenotypes using stable and regulated synthetic microRNA precursors , 2005, Nature Genetics.

[14]  Rui Wu,et al.  Tumor suppressor p53 meets microRNAs. , 2011, Journal of molecular cell biology.

[15]  Y. Choi,et al.  Signaling through cyclin D-dependent kinases , 2014, Oncogene.

[16]  S. Robinson,et al.  Transcription Factor in Melanoma Cell Lines MicroRNA-137 Targets Microphthalmia-Associated , 2008 .

[17]  M. Kok,et al.  CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system , 2003, Oncogene.

[18]  J. Mann,et al.  Arrested development and the great escape--the role of cellular senescence in pancreatic cancer. , 2014, The international journal of biochemistry & cell biology.

[19]  Hiroshi I. Suzuki,et al.  Modulation of microRNA processing by p53 , 2009, Nature.

[20]  T. Jiang,et al.  miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. , 2012, European journal of cancer.

[21]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[22]  R. DePinho,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[23]  Hao Li,et al.  miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6 , 2013, FEBS letters.

[24]  Gad Getz,et al.  KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors , 2013, Cell.

[25]  H. Erdjument-Bromage,et al.  Histone demethylation by a family of JmjC domain-containing proteins , 2006, Nature.

[26]  X. Chen,et al.  miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells , 2011, International journal of cancer.

[27]  R. Sullivan,et al.  Resistance to BRAF-targeted therapy in melanoma. , 2013, European journal of cancer.

[28]  P. Poulikakos,et al.  Targeting RAS–ERK signalling in cancer: promises and challenges , 2014, Nature Reviews Drug Discovery.

[29]  Qini Gan,et al.  PPARγ accelerates cellular senescence by inducing p16INK4α expression in human diploid fibroblasts , 2008, Journal of Cell Science.

[30]  N. Mongan,et al.  MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators , 2015, Oncotarget.

[31]  P. Pandolfi,et al.  PML is a direct p53 target that modulates p53 effector functions. , 2004, Molecular cell.

[32]  W. Filipowicz,et al.  The long unfinished march towards understanding microRNA-mediated repression , 2015, RNA.

[33]  Frédérick A. Mallette,et al.  Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor , 2012, Nucleic acids research.

[34]  Christos Sotiriou,et al.  MicroRNAs regulate KDM5 histone demethylases in breast cancer cells. , 2016, Molecular bioSystems.

[35]  Frédérick A. Mallette,et al.  RNF8‐ and RNF168‐dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites , 2012, The EMBO journal.

[36]  Frédérick A. Mallette,et al.  Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. , 2014, Immunity.

[37]  F. McCormick,et al.  Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation , 1997, Molecular and cellular biology.

[38]  Michael Ruogu Zhang,et al.  Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence , 2022 .

[39]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[40]  Pier Paolo Pandolfi,et al.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.

[41]  J. Wong,et al.  JMJD2A Is a Novel N-CoR-Interacting Protein and Is Involved in Repression of the Human Transcription Factor Achaete Scute-Like Homologue 2 (ASCL2/Hash2) , 2005, Molecular and Cellular Biology.

[42]  Jiahuai Han,et al.  Molecular and Cellular Pathobiology the Mir-17-92 Cluster of Micrornas Confers Tumorigenicity by Inhibiting Oncogene-induced Senescence , 2022 .

[43]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[44]  Fenghua Wang,et al.  Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer , 2012, Carcinogenesis.

[45]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[46]  J. Inazawa,et al.  Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.

[47]  G. Peters,et al.  Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts , 1998, Current Biology.

[48]  Yang Shi,et al.  Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases , 2006, Cell.

[49]  D. Esposito,et al.  Dragging ras back in the ring. , 2014, Cancer cell.

[50]  D. Woods,et al.  Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.

[51]  Young Eun Choi,et al.  Charity begins at home: non-coding RNA functions in DNA repair , 2013, Nature Reviews Molecular Cell Biology.

[52]  B. Wiedenmann,et al.  Tumor suppressor p16INK4a controls oncogenic K‐Ras function in human pancreatic cancer cells , 2012, Cancer science.

[53]  J. Otte,et al.  Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. , 1995, Nucleic acids research.

[54]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[55]  S. Lowe,et al.  PML is induced by oncogenic ras and promotes premature senescence. , 2000, Genes & development.

[56]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[57]  Reuven Agami,et al.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. , 2006, Cell.

[58]  J. Shay,et al.  A role for both RB and p53 in the regulation of human cellular senescence. , 1991, Experimental cell research.

[59]  Samir K. Brahmachari,et al.  Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a , 2009, Proceedings of the National Academy of Sciences.

[60]  Prasenjit Dey,et al.  Genetics and biology of pancreatic ductal adenocarcinoma , 2006, Genes & development.

[61]  Dimitris Kletsas,et al.  Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints , 2006, Nature.

[62]  M. Barbacid,et al.  Tumour biology: Senescence in premalignant tumours , 2005, Nature.

[63]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.

[64]  G. Peters,et al.  The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.

[65]  Charles J. Sherr,et al.  Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.

[66]  Frédérick A. Mallette,et al.  JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5. , 2012, Cell reports.

[67]  Krishna R. Kalari,et al.  FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. , 2009, Cancer cell.

[68]  Min Wang,et al.  microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. , 2014, International journal of clinical and experimental pathology.

[69]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[70]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[71]  Karl Munger,et al.  The papillomavirus E7 proteins. , 2013, Virology.

[72]  Frédérick A. Mallette,et al.  The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. , 2007, Genes & development.

[73]  H. Stein,et al.  Oncogene-induced senescence as an initial barrier in lymphoma development , 2005, Nature.

[74]  P. Pearson,et al.  Atmospheric carbon dioxide concentrations over the past 60 million years , 2000, Nature.

[75]  P. Howley,et al.  In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.

[76]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[77]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[78]  Simon Tavaré,et al.  Autophagy mediates the mitotic senescence transition. , 2009, Genes & development.

[79]  S. Robinson,et al.  MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. , 2008, Cancer research.

[80]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.